Pharmaceutical Benefits Act 1952

Overview

The Pharmaceutical Benefits Act 1952 was enacted to amend the Pharmaceutical Benefits Act 1947-1950. This legislation was introduced to address the need for more precise regulatory control over the constitution, powers, and functions of committees established under the Act, particularly those involved in the oversight of medical practitioners and pharmaceutical chemists. The Act was passed by the Queen’s Most Excellent Majesty, the Senate, and the House of Representatives of the Commonwealth of Australia and received Royal Assent on 1 November 1952. The policy objective underpinning this amendment was to ensure that any committee inquiries or advice involving the conduct of medical practitioners or pharmaceutical chemists are conducted by committees whose members, apart from those who are officers of the Public Service of the Commonwealth, are themselves medical practitioners or pharmaceutical chemists. This was to maintain the integrity and professional standards of the healthcare sector.

Scope and Application

The Pharmaceutical Benefits Act 1947-1952, as amended, applies to the establishment and regulation of committees that advise on pharmaceutical benefits within the Commonwealth of Australia. These committees are tasked with various functions, including advising on the constitution, powers, functions, duties, and procedure of committees established under the Act. Notably, these committees cannot inquire into or advise on matters concerning the conduct of medical practitioners or pharmaceutical chemists unless the committee members involved are of the same profession. The Act has a broad jurisdictional reach within Australia, extending to both state and territory courts, where it confers federal jurisdiction over matters arising under the regulations. Furthermore, the Act allows for the fixing of fees and allowances for committee members who are not officers of the Public Service of the Commonwealth or a state, providing flexibility in the remuneration of committee members. Any exclusions or restrictions on the application of the Act are defined through subordinate instruments, such as regulations that may be made under the authority of the Act.

Key Provisions

The Pharmaceutical Benefits Act 1952 introduces specific provisions to amend the Pharmaceutical Benefits Act 1947-1950. The Act is designed to provide a framework for the establishment of committees under the Pharmaceutical Benefits Scheme. Section 19 of the Principal Act is repealed and replaced to allow for the establishment of additional committees by the Minister for the purposes of the Act (section 19(1)). Importantly, these committees are restricted from inquiring into or advising on matters concerning the conduct of medical practitioners or pharmaceutical chemists unless all members of the committee who are not Public Service officers are themselves medical practitioners or pharmaceutical chemists respectively (section 19(2)). The Act imposes certain obligations on the Minister and the committees established under it. The Minister is given the authority to establish committees as needed, provided that the members of these committees meet the specified qualifications if they are to deal with matters concerning medical practitioners or pharmaceutical chemists. The committees themselves are expected to adhere to the prescribed constitution, powers, functions, duties, and procedures as outlined in the regulations. Additionally, the Act mandates that these committees can require persons to attend as witnesses and be examined under oath or affirmation (section 19(2)). Section 4 of the Act amends section 23 of the Principal Act to expand the regulatory powers of the Act. The regulations now include the authority to prescribe the constitution, powers, functions, duties, and procedures of committees, to fix fees and allowances for committee members who are not Public Service officers, and to confer jurisdiction on State and Territory courts for matters arising under the regulations (section 23(f)-(fc)). This amendment ensures that the Act can adapt to new requirements and provide clearer guidance on the operations of the committees. Failure to comply with the provisions of the Act may result in legal consequences. While the Act itself does not explicitly outline specific offences or penalties, breaches of regulations or improper conduct by committee members could potentially lead to legal action under other relevant legislation. The consequences could include fines, imprisonment, or other penalties as prescribed by the applicable laws. The exact penalties would depend on the nature of the breach and the relevant legal provisions governing such conduct.